Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Cash flows from operating activities:
Net income (loss)	$ 212	$ (807)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation, amortization and accretion expense	13,061	15,500
Amortization of deferred financing costs	290	428
Amortization of above market leases, net		(1)
Provision for losses on doubtful accounts	49	125
Deferred income taxes	(666)	(650)
Equity-based employee and director compensation expense	202	43
Amended Omnibus Agreement fees settled in common units		3,300
Loss (gain) on dispositions and lease terminations, net	59	(230)
Changes in operating assets and liabilities, net of acquisitions	(2,209)	432
Net cash provided by operating activities	10,998	18,140
Cash flows from investing activities:
Principal payments received on notes receivable	85	71
Proceeds from sale of property and equipment		19
Capital expenditures	(7,078)	(2,097)
Net cash used in investing activities	(6,993)	(2,007)
Cash flows from financing activities:
Borrowings under the revolving credit facility	31,834	40,395
Repayments on the revolving credit facility	(13,334)	(35,395)
Payments of long-term debt and finance lease obligations	(552)	(498)
Payments of sale leaseback obligations		(239)
Payment of deferred financing costs	(613)
Distributions paid on distribution equivalent rights	(16)	(10)
Distributions paid to holders of the IDRs	(133)	(1,180)
Distributions paid to noncontrolling interests		(18)
Distributions paid on common units	(18,083)	(21,405)
Net cash used in financing activities	(897)	(18,350)
Net increase (decrease) in cash and cash equivalents	3,108	(2,217)
Cash and cash equivalents at beginning of period	3,191	3,897
Cash and cash equivalents at end of period	$ 6,299	$ 1,680